Higher Dosage of HIFU Treatment May Lead to Higher and Longer Efficacy for Moderate to Severe Perennial Allergic Rhinitis

International Journal of Medical Sciences - Canada
doi 10.7150/ijms.7117
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Ivyspring International Publisher

Related search

MP29-02*’s Advanced Delivery System Contributes to Its Efficacy in Patients With Moderate/Severe Seasonal Allergic Rhinitis

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

Efficacy of Montelukast and Levocetirizine as Treatment for Allergic Rhinitis

Journal of Allergy & Therapy
2010English

Meta-Analysis of the Efficacy of Pharmacotherapies and Allergen Immunotherapy for Adult Perennial Allergic Rhinitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Higher-Dose Intravenous Magnesium Therapy for Children With Moderate to Severe Acute Asthma

Archives of Pediatrics & Adolescent Medicine
2000English

Blomia Tropicalis and Component Resolved Diagnosis: Performance Outcomes in Moderate-Severe Allergic Rhinitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Randomized, Open-Label, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Omalizumab in the Treatment of Persistent Moderate and Severe Allergic Asthma and Persistent Allergic Rhinitis in Pediatric Patients 6 to 17 Years of Age

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Increased Doses Lead to Higher Drug Exposures of Levofloxacin for the Treatment of Tuberculosis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Treatment of Allergic Rhinitis

1989English

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy